Papers

8

Total Citations

271

H-Index

6

About

Eva Angenete is a leading surgical researcher whose work centers on prostate cancer treatment, with a particular focus on comparing robot-assisted laparoscopic and open radical prostatectomy. Her major contributions stem from the landmark LAPPRO trial, a prospective, longitudinal multicenter study of over 4,000 patients. Through this work, she has provided crucial evidence on long-term functional and oncological outcomes, including an 8-year follow-up study (114 citations) and a 12-year analysis of prostate cancer-specific survival. Angenete has also advanced the field by conducting health economic analyses of surgical techniques (87 citations), demonstrating her commitment to understanding the real-world costs and benefits of new technologies. Beyond surgical comparisons, her research explores patient-reported outcomes, the impact of preoperative physical activity on recovery, and the psychological effects of a prostate cancer diagnosis, including negative intrusive thoughts and quality of life. Her work is notable for its rigorous methodology, combining clinical data with patient questionnaires to paint a comprehensive picture of patient experiences. With her research cited hundreds of times, Angenete has become a key voice in evidence-based urologic oncology.

Research Focus

Key Achievements

6
H-Index
8
Papers
271
Total Citations
34
Avg Citations/Paper
🏆 Most Cited Paper
Functional and Oncological Outcomes After Open Versus Robot-assisted Laparoscopic Radical Prostatectomy for Localised Prostate Cancer: 8-Year Follow-up
114 citations · 2021
📈 Most Prolific Year: 2019 (2 Papers)
🤝 Key Collaborators: 37
🏛 Institutions: Sahlgrenska University Hospital, University of Gothenburg

Top Papers

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago